However, because GDF15 can protect the pancreas from inflammation at least in type 1 diabetes (Nakayasu et al., 2020), and because DHODH inhibitors are used against autoimmune diseases, it is still possible that to some extent, DHODH inhibitors could protect the pancreas from inflammation. Here, DHODH is linked to type 1 diabetes mellitus.